Why Science's Most Effective Ebola Vaccine Remains Shelved

A fully tested Ebola vaccine proved highly effective against the Bundibugyo strain over a decade ago, yet remains locked in laboratory storage while the disease spreads in Africa. The gap between scientific validation and public health deployment reveals how funding constraints and market perceptions can prevent proven treatments from reaching patients in crisis. This case exemplifies a systemic failure in global health: the world invests in discovery but fails to fund implementation.